Cargando…

Random non-fasting C-peptide testing can identify patients with insulin-treated type 2 diabetes at high risk of hypoglycaemia

AIMS/HYPOTHESIS: The aim of this study was to determine whether random non-fasting C-peptide (rCP) measurement can be used to assess hypoglycaemia risk in insulin-treated type 2 diabetes. METHODS: We compared continuous glucose monitoring-assessed SD of blood glucose and hypoglycaemia duration in 17...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hope, Suzy V., Knight, Bridget A., Shields, Beverley M., Hill, Anita V., Choudhary, Pratik, Strain, W. David, McDonald, Timothy J., Jones, Angus G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6002965/ https://www.ncbi.nlm.nih.gov/pubmed/28983693 http://dx.doi.org/10.1007/s00125-017-4449-2

Ejemplares similares

Are we missing hypoglycaemia? Elderly patients with insulin-treated diabetes present to primary care frequently with non-specific symptoms associated with hypoglycaemia
por: Hope, Suzy V., et al.
Publicado: (2018)

Assessment of endogenous insulin secretion in insulin treated diabetes predicts postprandial glucose and treatment response to prandial insulin
por: Jones, Angus G, et al.
Publicado: (2012)

Urine C-peptide creatinine ratio can be used to assess insulin resistance and insulin production in people without diabetes: an observational study
por: Oram, Richard A, et al.
Publicado: (2013)

Insulin Hypoglycæmia
Publicado: (1948)

Urine C-Peptide Creatinine Ratio Is a Noninvasive Alternative to the Mixed-Meal Tolerance Test in Children and Adults With Type 1 Diabetes
por: Besser, Rachel E.J., et al.
Publicado: (2011)

Urinary C‐peptide creatinine ratio detects absolute insulin deficiency in Type 2 diabetes
por: Hope, S. V., et al.
Publicado: (2013)

Practical Classification Guidelines for Diabetes in patients treated with insulin: a cross-sectional study of the accuracy of diabetes diagnosis
por: Hope, Suzy V, et al.
Publicado: (2016)

Hypoglycaemia in type 1 diabetes: technological treatments, their limitations and the place of psychology
por: Choudhary, Pratik, et al.
Publicado: (2018)

The majority of patients with long-duration type 1 diabetes are insulin microsecretors and have functioning beta cells
por: Oram, Richard A., et al.
Publicado: (2013)

Lower Circulating B12 Is Associated with Higher Obesity and Insulin Resistance during Pregnancy in a Non-Diabetic White British Population
por: Knight, Bridget Ann, et al.
Publicado: (2015)

Erratum to: The majority of patients with long-duration type 1 diabetes are insulin microsecretors and have functioning beta cells
por: Oram, Richard A., et al.
Publicado: (2013)

The impact of hypoglycaemia awareness status on regional brain responses to acute hypoglycaemia in men with type 1 diabetes
por: Dunn, Joel T., et al.
Publicado: (2018)

Type 1 diabetes defined by severe insulin deficiency occurs after 30 years of age and is commonly treated as type 2 diabetes
por: Thomas, Nicholas J., et al.
Publicado: (2019)

Five-Year Follow-Up for Women With Subclinical Hypothyroidism in Pregnancy
por: Shields, Beverley M., et al.
Publicado: (2013)

Development and validation of multivariable clinical diagnostic models to identify type 1 diabetes requiring rapid insulin therapy in adults aged 18–50 years
por: Lynam, Anita, et al.
Publicado: (2019)

Persistent C‐peptide is associated with reduced hypoglycaemia but not HbA(1c) in adults with longstanding Type 1 diabetes: evidence for lack of intensive treatment in UK clinical practice?
por: Marren, S. M., et al.
Publicado: (2019)

A systematic review of the effect of prior hypoglycaemia on cognitive function in type 1 diabetes
por: Rama Chandran, Suresh, et al.
Publicado: (2020)

The Diagnosis and Management of Hyperinsulinaemic Hypoglycaemia
por: Roženková, Klára, et al.
Publicado: (2015)

EDTA Improves Stability of Whole Blood C-Peptide and Insulin to Over 24 Hours at Room Temperature
por: McDonald, Timothy J., et al.
Publicado: (2012)

Hypoglycaemia detection and prediction techniques: A systematic review on the latest developments
por: Diouri, Omar, et al.
Publicado: (2021)

Continuation of Liraglutide during Fasting is not Associated with Hypoglycaemia
por: Koot, Rosalie, et al.
Publicado: (2017)

Changes in attitudes to awareness of hypoglycaemia during a hypoglycaemia awareness restoration programme are associated with avoidance of further severe hypoglycaemia episodes within 24 months: the A2A in HypoCOMPaSS study
por: Sepúlveda, Eduardo, et al.
Publicado: (2022)

Altered functional connectivity during hypoglycaemia in type 1 diabetes
por: Jacob, Peter, et al.
Publicado: (2022)

Approach to assessing the economic impact of insulin‐related hypoglycaemia using the novel Local Impact of Hypoglycaemia Tool
por: Parekh, W. A., et al.
Publicado: (2015)

A meta‐analysis of rate ratios for nocturnal confirmed hypoglycaemia with insulin degludec vs. insulin glargine using different definitions for hypoglycaemia
por: Heller, S., et al.
Publicado: (2015)

Urinary C-Peptide Creatinine Ratio Is a Practical Outpatient Tool for Identifying Hepatocyte Nuclear Factor 1-α/Hepatocyte Nuclear Factor 4-α Maturity-Onset Diabetes of the Young From Long-Duration Type 1 Diabetes
por: Besser, Rachel E.J., et al.
Publicado: (2011)

Rates of hypoglycaemia are lower in patients treated with insulin degludec/liraglutide (IDegLira) than with IDeg or insulin glargine, regardless of the hypoglycaemia definition used
por: Norwood, Paul, et al.
Publicado: (2017)

Cost of severe hypoglycaemia in patients with type 1 diabetes in Spain and the cost-effectiveness of insulin lispro compared with regular human insulin in preventing severe hypoglycaemia
por: Reviriego, J, et al.
Publicado: (2008)

Can clinical features be used to differentiate type 1 from type 2 diabetes? A systematic review of the literature
por: Shields, Beverley M, et al.
Publicado: (2015)

Hypoglycæmia
Publicado: (1934)

Scoping review of evidence for managing postnatal hypoglycaemia
por: Horwitz, Jennifer, et al.
Publicado: (2022)

Hypoglycaemia as a function of HbA1c in type 2 diabetes: Insulin glargine 300 U/mL in a patient‐level pooled analysis of EDITION 1, 2 and 3
por: Bonadonna, Riccardo C., et al.
Publicado: (2018)

A parallel randomised controlled trial of the Hypoglycaemia Awareness Restoration Programme for adults with type 1 diabetes and problematic hypoglycaemia despite optimised self-care (HARPdoc)
por: Amiel, Stephanie A., et al.
Publicado: (2022)

An analysis of early insulin glargine added to metformin with or without sulfonylurea: impact on glycaemic control and hypoglycaemia
por: Fonseca, V, et al.
Publicado: (2011)

Severe hypoglycaemia during intensive insulin therapy: a rare event in critically ill patients
por: Kaukonen, M, et al.
Publicado: (2007)

Diazoxide-responsive hyperinsulinaemic hypoglycaemia in tyrosinaemia type 1
por: Sotiridou, Ellada, et al.
Publicado: (2021)

Evaluating the relationships of hypoglycaemia and HbA1c with screening‐detected diabetes distress in type 1 diabetes
por: Todd, Peter J., et al.
Publicado: (2017)

A study of association between common variation in the growth hormone-chorionic somatomammotropin hormone gene cluster and adult fasting insulin in a UK Caucasian population
por: Freathy, Rachel M, et al.
Publicado: (2006)

Identifying clinical criteria to predict Type 1 diabetes, as defined by absolute insulin deficiency: a systematic review protocol
por: Shields, Beverley M, et al.
Publicado: (2012)

Severe hypoglycaemia in adults with insulin‐treated diabetes: impact on healthcare resources
por: Heller, S. R., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_9e08nl3i05jfrt4pmvac5o2bts